These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 33292080)

  • 1. Cyclic peptide engineered from phytocystatin inhibitory hairpin loop as an effective modulator of falcipains and potent antimalarial.
    Mishra M; Singh V; Tellis MB; Joshi RS; Pandey KC; Singh S
    J Biomol Struct Dyn; 2022 May; 40(8):3642-3654. PubMed ID: 33292080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Cysteine Proteases from Plasmodium falciparum: A General Overview, Rational Drug Design and Computational Approaches for Drug Discovery.
    Bekono BD; Ntie-Kang F; Owono Owono LC; Megnassan E
    Curr Drug Targets; 2018; 19(5):501-526. PubMed ID: 28003005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Falcipain cysteine proteases of malaria parasites: An update.
    Rosenthal PJ
    Biochim Biophys Acta Proteins Proteom; 2020 Mar; 1868(3):140362. PubMed ID: 31927030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cysteine proteases of malaria parasites.
    Rosenthal PJ
    Int J Parasitol; 2004 Dec; 34(13-14):1489-99. PubMed ID: 15582526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Plasmodium falciparum cysteine proteases by the sugarcane cystatin CaneCPI-4.
    Melo PMS; El Chamy Maluf S; Azevedo MF; Paschoalin T; Budu A; Bagnaresi P; Henrique-Silva F; Soares-Costa A; Gazarini ML; Carmona AK
    Parasitol Int; 2018 Apr; 67(2):233-236. PubMed ID: 29288140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of non-peptidic compounds as potential malarial inhibitors against Plasmodial cysteine proteases via integrated virtual screening workflow.
    Musyoka TM; Kanzi AM; Lobb KA; Tastan Bishop Ö
    J Biomol Struct Dyn; 2016 Oct; 34(10):2084-101. PubMed ID: 26471975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Falcipains and other cysteine proteases of malaria parasites.
    Rosenthal PJ
    Adv Exp Med Biol; 2011; 712():30-48. PubMed ID: 21660657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of antimalarial leads with dual falcipain-2 and falcipain-3 inhibitory activity.
    Rana D; Kalamuddin M; Sundriyal S; Jaiswal V; Sharma G; Das Sarma K; Sijwali PS; Mohmmed A; Malhotra P; Mahindroo N
    Bioorg Med Chem; 2020 Jan; 28(1):115155. PubMed ID: 31744777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BDA-410: a novel synthetic calpain inhibitor active against blood stage malaria.
    Li X; Chen H; Jeong JJ; Chishti AH
    Mol Biochem Parasitol; 2007 Sep; 155(1):26-32. PubMed ID: 17583361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prodomain peptide of Plasmodium falciparum cysteine protease (falcipain-2) inhibits malaria parasite development.
    Korde R; Bhardwaj A; Singh R; Srivastava A; Chauhan VS; Bhatnagar RK; Malhotra P
    J Med Chem; 2008 Jun; 51(11):3116-23. PubMed ID: 18461922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimalarial activities of novel synthetic cysteine protease inhibitors.
    Lee BJ; Singh A; Chiang P; Kemp SJ; Goldman EA; Weinhouse MI; Vlasuk GP; Rosenthal PJ
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3810-4. PubMed ID: 14638488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemoglobin Degrading Proteases of Plasmodium falciparum as Antimalarial Drug Targets.
    Qidwai T
    Curr Drug Targets; 2015; 16(10):1133-41. PubMed ID: 25738296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemoglobin cleavage site-specificity of the Plasmodium falciparum cysteine proteases falcipain-2 and falcipain-3.
    Subramanian S; Hardt M; Choe Y; Niles RK; Johansen EB; Legac J; Gut J; Kerr ID; Craik CS; Rosenthal PJ
    PLoS One; 2009; 4(4):e5156. PubMed ID: 19357776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of (4-(9H-fluoren-9-yl) piperazin-1-yl) methanone derivatives as falcipain 2 inhibitors active against Plasmodium falciparum cultures.
    Hernández-González JE; Salas-Sarduy E; Hernández Ramírez LF; Pascual MJ; Álvarez DE; Pabón A; Leite VBP; Pascutti PG; Valiente PA
    Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2911-2923. PubMed ID: 30253205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of whole genome sequence data on drug discovery--a malaria case study.
    Joachimiak MP; Chang C; Rosenthal PJ; Cohen FE
    Mol Med; 2001 Oct; 7(10):698-710. PubMed ID: 11713369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing sequence and structure of falcipains and human homologs at prodomain and catalytic active site for malarial peptide based inhibitor design.
    Musyoka TM; Njuguna JN; Tastan Bishop Ö
    Malar J; 2019 May; 18(1):159. PubMed ID: 31053072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Falcipains: Biochemistry, target validation and structure-activity relationship studies of inhibitors as antimalarials.
    Patra J; Rana D; Arora S; Pal M; Mahindroo N
    Eur J Med Chem; 2023 Apr; 252():115299. PubMed ID: 36996716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Plasmodium falciparum digestive vacuole plasmepsins in the specificity and antimalarial mode of action of cysteine and aspartic protease inhibitors.
    Moura PA; Dame JB; Fidock DA
    Antimicrob Agents Chemother; 2009 Dec; 53(12):4968-78. PubMed ID: 19752273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of new antimalarial agents: Second-generation dual inhibitors against FP-2 and PfDHFR via fragments assembely.
    Chen W; Huang Z; Wang W; Mao F; Guan L; Tang Y; Jiang H; Li J; Huang J; Jiang L; Zhu J
    Bioorg Med Chem; 2017 Dec; 25(24):6467-6478. PubMed ID: 29111368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three Decades of Targeting Falcipains to Develop Antiplasmodial Agents: What have we Learned and What can be Done Next?
    González JEH; Salas-Sarduy E; Alvarez LH; Valiente PA; Arni RK; Pascutti PG
    Curr Med Chem; 2024; 31(16):2234-2263. PubMed ID: 37711130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.